|
|
|
|
|
|
|
Free Newsletters
Archive
My Subscriptions
News by Subject
News by Disease
News by Date
PLoS
Search News
Post Your News
JoVE
Job Seeker Login
Most Recent Jobs
Browse Biotech Jobs
Search Jobs
Post Resume
Career Fairs
Career Resources
For Employers
Regional News
US & Canada
Biotech Bay
Biotech Beach
Genetown
Pharm Country
BioCapital
BioMidwest
Bio NC
BioForest
Southern Pharm
BioCanada East
US Device
Europe
Asia
Market Summary
News
IPOs
Company Profiles
Companies
Events
Research Store
Biotech Events
Post an Event
Real Estate
Business Opportunities
|
|
|
|
|
News | News By Subject | News by Disease |
News By Date | Search News
|
|
|
Oncology Med Enters Into Letter of Intent to Acquire Medical/Radiation Company Which Has Gross Revenues of $2,800,000.00
1/30/2008 8:55:44 AM
PITTSBURGH, PA--(Marketwire - January 30, 2008) - Oncology Med, Inc. (PINKSHEETS: ONCO) a Pittsburgh based cancer treatment solutions group, announced today that it has entered into a letter of intent to acquire a synergistic company in the field of physics and radiation that has annual revenues of $2,800,000.00, operates on a national scale, and is profitable. Upon the closing of this acquisition, which is subject to due diligence review by both parties and the execution of definitive agreements of purchase, the combined entity will have an annual revenue run rate of $5,000,000.00. The Company is prevented from announcing the name of the acquisition candidate until the completion of the due diligence period and execution of a definitive agreement of purchase.
|
|
|
|
|
|
|
|
|
|
|